QLB Biotherapeutics Inc., located in Boston, Massachusetts, is a startup biotechnology company focusing on discovering and developing biological therapeutics. QLB Bio is funded by Qilu Pharmaceutical, and will become its biggest overseas Research and Development Center. QLB Bio is devoted to developing next-generation cancer therapeutics using the transformative potential of immunotherapy. We have an ambitious vision and a growing pipeline of novel cancer immunotherapy biological candidates to treat solid tumors as well as hematologic cancers. To achieve our mission, we seek highly motivated professionals who share our dedication to patients and our passion for discovery, innovation and scientific rigor.
Company Details
- Employees
- 5
- Address
- 50 Soldiers Field Pl, Boston,massachusetts,united States
- Industry
- Biotechnology
- Website
- qlb-bio.com
- HQ
- Boston, Massachusetts
Qlb Biotherapeutics Questions
Qlb Biotherapeutics's website is qlb-bio.com
Qlb Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/qlb-biotherapeutics
Qlb Biotherapeutics has
5 employees.
View email and phone details for 5
employees at Qlb Biotherapeutics.
Qlb Biotherapeutics's industry is
Biotechnology
Qlb Biotherapeutics's top competitors are
Tenaya Therapeutics,
Larkspur Biosciences,
Elevatebio,
Qilu Pharmaceuticals,
Flare Therapeutics,
Truebinding,
齐鲁制药有限公司,
Simnova Biotherapeutics,
Qld Biotherapeutics Inc,
Qilu Pharma Spain.
Qlb Biotherapeutics's categories are Biotechnology
